Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Method Enables Precise Detection of Nanoplastics in Body

By LabMedica International staff writers
Posted on 03 Sep 2025

Nanoplastic particles, with diameters under 0. More...

001 millimeters, can penetrate body tissue and accumulate in organs. Because they are difficult to detect precisely, research into the health impacts of microplastics and nanoplastics (MNP) has remained challenging. A new approach now enables the reliable tracking of these particles from ingestion to the cellular level, providing the first detailed insights into their behavior within the body.

The new method, developed by researchers from MedUni Vienna (Vienna, Austria) and the University of Hamburg (Hamburg, Germany), as well as collaborators, combines three analytical techniques. These include inductively coupled plasma mass spectrometry (ICP-MS) for quantification, X-ray fluorescence imaging (XFI) for localizing particles in tissue, and imaging mass cytometry (IMC) for mapping distribution at the cellular level. By labeling nanoplastics with palladium, the team enabled detailed tracking of their fate in the body.

Mouse models were tested under three exposure conditions: single short-term intake, medium-term exposure over ten days, and long-term exposure over five weeks. The findings, published in Nature Communications Biology, showed that most particles are excreted quickly after one intake, but prolonged exposure led to accumulation in organs such as the liver, kidneys, and brain. In mice with impaired intestinal barriers or altered intestinal movement, excretion slowed, increasing tissue uptake.

The new method provides both quantitative and spatial analyses of nanoplastics, overcoming limitations of earlier approaches. This allows researchers to more accurately investigate potential health risks linked to chronic exposure. The technique can help clarify how these particles interact with biological systems, laying the groundwork for future studies on long-term health effects and possible preventive measures.

“The significance of our study lies less in these biological observations themselves than in the development of a methodological approach that combines quantitative and spatial analyses for the first time,” said Lukas Kenner, Clinical Department of Pathology, MedUni Vienna.

Related Links:
MedUni Vienna
University of Hamburg


New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Genetic Type 1 Diabetes Risk Test
T1D GRS Array
Urine Chemistry Control
Dropper Urine Chemistry Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.